Comparison between two drugs in treatment of ear perforation.
Phase 4
- Conditions
- Health Condition 1: H661- Chronic tubotympanic suppurative otitis media
- Registration Number
- CTRI/2022/07/043743
- Lead Sponsor
- Department of Otorhinolaryngology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with tubo-tympanic chronic suppurative otitis media in both sexes with age between 15 to 60 years.
2.Only outpatients will be included.
3.Patients with tubotympanic chronic suppurative otitis media with atleast moderate central perforation.
Exclusion Criteria
1. Age group below 15 and above 60 of all sexes
2. Attico antral type of CSOM
3. Complicated CSOM
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to compare which eardrop is better in releiving the complain of ear discharge.Timepoint: 14 days
- Secondary Outcome Measures
Name Time Method Whichever is best for maintaining primary outcome of study.Timepoint: 1 month